Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Ziyan Chen"'
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 22:409-415
Hepatic encephalopathy (HE) is a complex and reversible neuropsychiatric syndrome that is associated with growing, substantial healthcare resource utilization. We aim to examine the predictors of 30-day readmission and hospitalization cost associated
Autor:
Baofu Zhang, Wenming Bao, Sina Zhang, Bo Chen, Xiang Zhou, Jungang Zhao, Zhehao Shi, Tan Zhang, Ziyan Chen, Luhui Wang, Xiangtao Zheng, Gang Chen, Yi Wang
Publikováno v:
Cell Death & Disease. 13
Ferroptosis is a new type of cell death that has been recognized in recent years and is different from apoptosis, autophagy, and necrosis. It is mainly due to cellular iron homeostasis and lipid peroxidation of iron metabolism caused by large accumul
Autor:
Lihui Wen, Ziyan Chen, Ziyi Jin, Wenyou Pan, Lin Liu, Min Wu, Fuwan Ding, Huaixia Hu, Xiang Ding, Hua Wei, Yaohong Zou, Xian Qian, Meimei Wang, Jian Wu, Juan Tao, Jun Tan, Zhanyun Da, Miaojia Zhang, Jing Li, Xuebing Feng, Jun Liang, Huayong Zhang, Lingyun Sun
Publikováno v:
Scientific Reports. 12
Studies on clinical features of systemic lupus erythematosus among different age-onset patients are lacking in China. This multicentre study aimed to systemically compare clinical manifestations, comorbidities, organ involvement, and laboratory findi
Impact of sarcopenia on outcomes of patients undergoing liver resection for hepatocellular carcinoma
Autor:
Jinhuan Yang, Kaiwen Chen, Chongming Zheng, Kaiyu Chen, Jian Lin, Qishan Meng, Ziyan Chen, Liming Deng, Haitao Yu, Tuo Deng, Zhiyuan Bo, Qikuan He, Yi Wang, Gang Chen
Publikováno v:
Journal of cachexia, sarcopenia and muscle. 13(5)
Previous studies have indicated that sarcopenia is associated with poor post-operative outcomes in liver cancer patients, but the studies are limited by confounding from mixed diseases, retrospective data, and non-standardized measurement methods. At
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 21:923-941
Introduction: Novel immunotherapeutic agents (e.g. monoclonal antibodies, antibody-drug conjugates, bispecific T-cell engagers) as treatment options for hematologic malignancies continue to emerge. These agents have been used as the standard of care
Autor:
Gang Chen, Yi Wang, Ziyan Chen, XiXiang Yu, Qian Ye, Kaiyu Chen, Jinhuan Yang, Mingliang Wu, Tuo Deng, Chen Jin
Publikováno v:
Aging (Albany NY)
Increased glycolysis has been reported as a major metabolic hallmark in many cancers, and is closely related to malignant behavior of tumors. However, the potential mechanism of glycolysis in hepatocellular carcinoma (HCC) and its prognostic value ar
Autor:
Jungang Zhao, Rizhao Li, Jiacheng Li, Ziyan Chen, Zixia Lin, Baofu Zhang, Liming Deng, Gang Chen, Yi Wang
Publikováno v:
Journal of translational medicine. 20(1)
Background The tumour microenvironment and cirrhotic liver are excellent sources of cancer-associated fibroblasts (CAFs), which participate in carcinogenesis. Thus, it is important to clarify the crosstalk between CAFs and HCC cells and the related m
Autor:
Jialiang Li, Zhengping Yu, Zhi-Yong Du, Han-Bin Chen, Qiandong Zhu, Xiwei Ding, Peirong Gong, Qiqiang Zeng, Gang Chen, Xiaozai Xie, Xin-Fei Yao, Sina Zhang, Yi Wang, Zhen Yang, Ziyan Chen, Longyun Ye, Junjian Li
Publikováno v:
Aging (Albany NY)
Cholangiocarcinoma (CCA) is a fatal disease with dismal survival rates. Long non-coding RNA (lncRNA) expression profiling as potential prognostic biomarkers play critical roles in tumor initiation, development, and poor prognosis. Identifying specifi
Autor:
Siqi, Tan, Ziyan, Chen, Yueqi, Qiu, Suhan, Zhang, Yanshan, Zhu, Xiaochao, Zhang, Siying, Li, Cheng, Cao, Yuwen, Su, Yu, Liu
Publikováno v:
European journal of dermatology : EJD. 32(1)
Autor:
Ziyan Chen, Bangjie He, Jungang Zhao, Jiacheng Li, Yifeng Zhu, Leilei Li, Wenming Bao, Jiuyi Zheng, Haitao Yu, Gang Chen
Publikováno v:
Phytomedicine : international journal of phytotherapy and phytopharmacology. 104
Intrahepatic cholangiocarcinoma (ICC) is a malignancy with a hidden onset, high metastasis recurrence rate, and poor prognosis. Research on effective drugs for ICC is important for improving the prognosis of patients in the clinic. Brusatol is a quas